Thulium laser enucleation of prostate: Novel therapy for benign prostatic hyperplasia
Background: Transurethral resection of the prostate (TURP) has been the undisputed gold standard treatment for benign prostatic enlargement (BPE). However, morbidity after TURP remains significant with increased risk of bleeding and TUR syndrome. In recent years, the role of laser technology in endo...
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Wolters Kluwer Health/LWW
2022-01-01
|
| Ráidu: | Formosan Journal of Surgery |
| Fáttát: | |
| Liŋkkat: | http://www.e-fjs.org/article.asp?issn=1682-606X;year=2022;volume=55;issue=1;spage=20;epage=26;aulast=Kant |
| _version_ | 1827882793719300096 |
|---|---|
| author | Shahil Kant Rajeev R Chaudhari Aman Gupta Bonny Shah Satyadev Sharma |
| author_facet | Shahil Kant Rajeev R Chaudhari Aman Gupta Bonny Shah Satyadev Sharma |
| author_sort | Shahil Kant |
| collection | DOAJ |
| description | Background: Transurethral resection of the prostate (TURP) has been the undisputed gold standard treatment for benign prostatic enlargement (BPE). However, morbidity after TURP remains significant with increased risk of bleeding and TUR syndrome. In recent years, the role of laser technology in endoscopic prostatic surgery has gradually increased. In our study, we evaluate the efficacy and safety of a novel technique of Thulium laser enucleation of prostate (THULEP) in the treatment of BPE.
Materials and Methods: Five hundred and thirty-six patients with symptomatic benign prostatic hyperplasia (BPH) were treated with THULEP. The inclusion criteria were acute retention of urine with the failure of trial without catheter, dissatisfaction with medical treatment, maximum urinary flow rate (Qmax) <15 ml/s, and International Prostate Symptoms Score (IPSS) >15. Patients were evaluated by Digital rectal examination (DRE), uroflowmetry, IPSS, prostate-specific antigen (PSA), blood and urine routine tests, abdominal ultrasonography, and trans-rectal ultrasonography (TRUS).
Results: The efficacy of THULEP was assessed by comparing preoperative variables with postoperative data. IPSS score got reduced from 24 to 3.5, quality of life score improved to 0–1 from 4–5. Qmax improved from mean 7 to 20 ml/s, Postvoid residue reduced from a mean of 110 to 12 ml. Hospital stay was < 36 h in the majority of patients. The average operative time was 45 min. No postoperative blood transfusion was required.
Conclusion: THULEP is a safe procedure and has a lesser number of complications. THULEP can replace monopolar TURP as a gold standard for the treatment of BPH. |
| first_indexed | 2024-03-12T19:02:49Z |
| format | Article |
| id | doaj.art-f5bd2c9fe5244caaafb11fa419cab505 |
| institution | Directory Open Access Journal |
| issn | 1682-606X |
| language | English |
| last_indexed | 2024-03-12T19:02:49Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Health/LWW |
| record_format | Article |
| series | Formosan Journal of Surgery |
| spelling | doaj.art-f5bd2c9fe5244caaafb11fa419cab5052023-08-02T06:29:55ZengWolters Kluwer Health/LWWFormosan Journal of Surgery1682-606X2022-01-01551202610.4103/fjs.fjs_206_20Thulium laser enucleation of prostate: Novel therapy for benign prostatic hyperplasiaShahil KantRajeev R ChaudhariAman GuptaBonny ShahSatyadev SharmaBackground: Transurethral resection of the prostate (TURP) has been the undisputed gold standard treatment for benign prostatic enlargement (BPE). However, morbidity after TURP remains significant with increased risk of bleeding and TUR syndrome. In recent years, the role of laser technology in endoscopic prostatic surgery has gradually increased. In our study, we evaluate the efficacy and safety of a novel technique of Thulium laser enucleation of prostate (THULEP) in the treatment of BPE. Materials and Methods: Five hundred and thirty-six patients with symptomatic benign prostatic hyperplasia (BPH) were treated with THULEP. The inclusion criteria were acute retention of urine with the failure of trial without catheter, dissatisfaction with medical treatment, maximum urinary flow rate (Qmax) <15 ml/s, and International Prostate Symptoms Score (IPSS) >15. Patients were evaluated by Digital rectal examination (DRE), uroflowmetry, IPSS, prostate-specific antigen (PSA), blood and urine routine tests, abdominal ultrasonography, and trans-rectal ultrasonography (TRUS). Results: The efficacy of THULEP was assessed by comparing preoperative variables with postoperative data. IPSS score got reduced from 24 to 3.5, quality of life score improved to 0–1 from 4–5. Qmax improved from mean 7 to 20 ml/s, Postvoid residue reduced from a mean of 110 to 12 ml. Hospital stay was < 36 h in the majority of patients. The average operative time was 45 min. No postoperative blood transfusion was required. Conclusion: THULEP is a safe procedure and has a lesser number of complications. THULEP can replace monopolar TURP as a gold standard for the treatment of BPH.http://www.e-fjs.org/article.asp?issn=1682-606X;year=2022;volume=55;issue=1;spage=20;epage=26;aulast=Kantbenign prostatic hyperplasiaholmium laser enucleation of the prostatemonopolar transurethral resection of the prostatethulium laser enucleation of prostate |
| spellingShingle | Shahil Kant Rajeev R Chaudhari Aman Gupta Bonny Shah Satyadev Sharma Thulium laser enucleation of prostate: Novel therapy for benign prostatic hyperplasia Formosan Journal of Surgery benign prostatic hyperplasia holmium laser enucleation of the prostate monopolar transurethral resection of the prostate thulium laser enucleation of prostate |
| title | Thulium laser enucleation of prostate: Novel therapy for benign prostatic hyperplasia |
| title_full | Thulium laser enucleation of prostate: Novel therapy for benign prostatic hyperplasia |
| title_fullStr | Thulium laser enucleation of prostate: Novel therapy for benign prostatic hyperplasia |
| title_full_unstemmed | Thulium laser enucleation of prostate: Novel therapy for benign prostatic hyperplasia |
| title_short | Thulium laser enucleation of prostate: Novel therapy for benign prostatic hyperplasia |
| title_sort | thulium laser enucleation of prostate novel therapy for benign prostatic hyperplasia |
| topic | benign prostatic hyperplasia holmium laser enucleation of the prostate monopolar transurethral resection of the prostate thulium laser enucleation of prostate |
| url | http://www.e-fjs.org/article.asp?issn=1682-606X;year=2022;volume=55;issue=1;spage=20;epage=26;aulast=Kant |
| work_keys_str_mv | AT shahilkant thuliumlaserenucleationofprostatenoveltherapyforbenignprostatichyperplasia AT rajeevrchaudhari thuliumlaserenucleationofprostatenoveltherapyforbenignprostatichyperplasia AT amangupta thuliumlaserenucleationofprostatenoveltherapyforbenignprostatichyperplasia AT bonnyshah thuliumlaserenucleationofprostatenoveltherapyforbenignprostatichyperplasia AT satyadevsharma thuliumlaserenucleationofprostatenoveltherapyforbenignprostatichyperplasia |